melanomanewstoday.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Disallow: */xmlrpc.php Disallow: */wp-*.php Disallow: */trackback/ Disallow: *?wptheme= Disallow: *?comments= Disallow: *?replytocom Disallow: */comment-page- Disallow: *?s= Disallow: /feed/ Disallow: /tag/* Disallow: /readme.html Allow: /wp-admin/admin-ajax.php Sitemap: | ||
Meta Tags
| Title | Melanoma News Today - Melanoma News |
| Description | Home About Melanoma Keytruda (Pembrolizumab) Melanoma Clinical Trials Contact Us Search for: June 8, 2017 August 24, 2022 Keytruda Improves Survival in Ad |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 104.21.8.131 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
melanomanewstoday.com Valuation
|
US$1,973,357
Last updated: 2023-05-12 06:26:23
melanomanewstoday.com has Semrush global rank of 5,363,603. melanomanewstoday.com has an estimated worth of US$ 1,973,357, based on its estimated Ads revenue. melanomanewstoday.com receives approximately 227,696 unique visitors each day. Its web server is located in United States, with IP address 104.21.8.131. According to SiteAdvisor, melanomanewstoday.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,973,357 |
| Daily Ads Revenue | US$1,822 |
| Monthly Ads Revenue | US$54,647 |
| Yearly Ads Revenue | US$655,762 |
| Daily Unique Visitors | 15,180 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| melanomanewstoday.com. | A | 300 | IP: 104.21.8.131 |
| melanomanewstoday.com. | A | 300 | IP: 172.67.188.116 |
| melanomanewstoday.com. | AAAA | 300 | IPV6: 2606:4700:3030::ac43:bc74 |
| melanomanewstoday.com. | AAAA | 300 | IPV6: 2606:4700:3037::6815:883 |
| melanomanewstoday.com. | NS | 86400 | NS Record: jasmine.ns.cloudflare.com. |
| melanomanewstoday.com. | NS | 86400 | NS Record: aiden.ns.cloudflare.com. |
| melanomanewstoday.com. | MX | 300 | MX Record: 0 mail.melanomanewstoday.com. |
| melanomanewstoday.com. | TXT | 300 | TXT Record: v=spf1 a mx ptr include:bluehost.com ?all |
HtmlToTextCheckTime:2023-05-12 06:26:23
| Home About Melanoma Keytruda (Pembrolizumab) Melanoma Clinical Trials Contact Us Search for: June 8, 2017 August 24, 2022 Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows News Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more June 6, 2017 New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test News Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more June 1, 2017 June 2, 2017 Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer News Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more May 30, 2017 Researchers Provide New Insights into Melanoma Immune |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Fri, 03 Dec 2021 08:53:52 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Fri, 03 Dec 2021 09:53:52 GMT
Location: https://melanomanewstoday.com/
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=SOSxrSf9TJqcuSqEfOW8JYxDG5E9GwnEc9abwywQSJPcQ8rMuqcQlGeRBSzOmSQSk%2BNDcv1ipXGZPIWPQmBO53uY5ZqwFqtn4rYx1UvB0oFAZHesyQYGROw8Yh%2BSLPVLz%2FkP3QYObe4%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6b7b912a5db6330c-EWR
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
HTTP/2 200
date: Fri, 03 Dec 2021 08:53:52 GMT
content-type: text/html
last-modified: Fri, 19 Nov 2021 21:24:32 GMT
vary: Accept-Encoding
cache-control: no-store, no-cache, must-revalidate
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=ognEdNl328j880cL3w3JXdKStRikI2WNeFhHOCp%2Bj80D8PMqBIwNAG3A%2FnxranKmBp0c0DfJsmERT%2BS6j0lg6HhkidHNrhNid7lnGah1p%2BKs%2B2bXLUnwqbtGKImmEZuUImVwk72uAC8%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6b7b912a8a6d19db-EWR
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
|
melanomanewstoday.com Whois Information
Domain Name: MELANOMANEWSTODAY.COM Registry Domain ID: 1848420630_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.fastdomain.com Registrar URL: http://www.fastdomain.com Updated Date: 2021-02-11T15:49:28Z Creation Date: 2014-02-27T13:10:38Z Registry Expiry Date: 2022-02-27T13:10:38Z Registrar: FastDomain Inc. Registrar IANA ID: 1154 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: AIDEN.NS.CLOUDFLARE.COM Name Server: JASMINE.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-09T07:29:56Z <<< |